Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Effect of troglitazone on fibrinolysis and activated coagulation in patients with non-insulin-dependent diabetes mellitus.

Fonseca VA, Reynolds T, Hemphill D, Randolph C, Wall J, Valiquet TR, Graveline J, Fink LM.

J Diabetes Complications. 1998 Jul-Aug;12(4):181-6.

PMID:
9647334
2.

Troglitazone: an antidiabetic agent.

Chen C.

Am J Health Syst Pharm. 1998 May 1;55(9):905-25. Review.

PMID:
9588250
3.

Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes.

Scheen AJ, Lefèbvre PJ.

Diabetes Care. 1999 Sep;22(9):1568-77. Review.

4.

Troglitazone.

Spencer CM, Markham A.

Drugs. 1997 Jul;54(1):89-101; discussion 102. Review.

PMID:
9211083
5.

The role of troglitazone in treating the insulin resistance syndrome.

Granberry MC, Schneider EF, Fonseca VA.

Pharmacotherapy. 1998 Sep-Oct;18(5):973-87. Review.

PMID:
9758309
6.

Troglitazone and related compounds: therapeutic potential beyond diabetes.

Fujiwara T, Horikoshi H.

Life Sci. 2000 Oct 6;67(20):2405-16. Review.

PMID:
11065164
7.

Effects of troglitazone on insulin sensitivity.

Henry RR.

Diabet Med. 1996 Sep;13(9 Suppl 6):S148-50. Review.

PMID:
8894499
8.

Troglitazone: a review of its use in the management of type 2 diabetes mellitus.

Plosker GL, Faulds D.

Drugs. 1999 Mar;57(3):409-38. Review.

PMID:
10193691
9.

Troglitazone in type II diabetes mellitus.

Sparano N, Seaton TL.

Pharmacotherapy. 1998 May-Jun;18(3):539-48. Review.

PMID:
9620105
10.

[The thiazolidinones--a new therapeutic agent for type 2 diabetes].

Bethge H, Häring HU.

Arzneimittelforschung. 1998 Feb;48(2):97-119. Review. German.

PMID:
9541719
11.
12.

Troglitazone: a new antihyperglycemic agent.

Vidt DG, Speerhas RA, Reddy SS.

Cleve Clin J Med. 1997 May;64(5):238-40. Review.

PMID:
9149473
13.

[Cardiovascular effects of the thiazolidinedione troglitazone].

Yamada K, Kuzuya H, Nakano T.

Nihon Rinsho. 2000 Feb;58(2):435-9. Review. Japanese.

PMID:
10707572
14.

Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus.

Johnson MD, Campbell LK, Campbell RK.

Ann Pharmacother. 1998 Mar;32(3):337-48. Review.

PMID:
9533065
15.

Troglitazone.

Santiago JV.

Compr Ther. 1997 Aug;23(8):560-2. Review. No abstract available.

PMID:
9283746
16.

New therapeutic agents for the treatment of NIDDM.

Kuehnle HF.

Exp Clin Endocrinol Diabetes. 1996;104(2):93-101. Review.

PMID:
8740931
17.

Thiazolidinediones--the new insulin enhancers.

Jha RJ.

Clin Exp Hypertens. 1999 Jan-Feb;21(1-2):157-66. Review.

PMID:
10052651
18.

Cardiovascular effects of troglitazone.

Umland EM, Romanelli AM.

Ann Pharmacother. 1999 Feb;33(2):229-32. Review. No abstract available.

PMID:
10084419
19.

[Diabetes mellitus].

Kawano M, Kanazawa Y.

Nihon Rinsho. 2000 Feb;58(2):421-5. Review. Japanese.

PMID:
10707569
20.

Potential role of thiazolidinediones in older diabetic patients.

Umeda F.

Drugs Aging. 1995 Nov;7(5):331-7. Review. No abstract available.

PMID:
8573988

Supplemental Content

Support Center